Technology Networks

Invitrogen Introduces Omnia™ Kinase Assays

Date Posted: Monday, May 29, 2006

Print Email to a friend

Invitrogen Corporation has announced the launch of its Omnia™ Kinase Assays for the rapid, homogenous and sensitive detection of enzymatic activity under physiological ATP concentrations. 

Scientists can mix reagents, read real-time fluorescent signals and get results in under an hour. 

Omnia™ is designed to offer a simple mix and read procedure, streamlining assay set-up and speeding data collection.

Further Information: http://www.invitrogen.com

Request Information From Vendor



Related Products

Invitrogen Launches Biomarker Tool for Pre-Clinical Research into Kidney Function
New assay panel enables non-invasive kidney transplantation immune response and tolerance studies.



Related news from our archive

Invitrogen Presents Latest Trends in Stem Cell Technologies at ISSCR Meeting
Tutorials provide insight into pioneering approaches for culture and expansion of multiple human cell types.